Cibc World Market Inc. Halozyme Therapeutics, Inc. Transaction History

Cibc World Market Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$40.06 - $59.44 $1.09 Million - $1.62 Million	27,214 New	27,214 $1.55 Million
Q1 2021 May 11, 2021	SELL	$39.51 - $51.45 $4.38 Million - $5.7 Million	-110,828 Closed	0 $0
Q4 2020 Feb 08, 2021	BUY	$25.81 - $43.62 $2.86 Million - $4.83 Million	110,828 New	110,828 $4.73 Million

543

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $6.62B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

Stay updated on Cibc World Market Inc. with notifications on news.